EP 1804810 A1 20070711 - METHODS USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE
Title (en)
METHODS USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE
Title (de)
VERFAHREN UNTER VERWENDUNG VON GLYCOSAMINOGLYKANEN ZUR BEHANDLUNG VON NIERENERKRANKUNGEN
Title (fr)
METHODES DE TRAITEMENT DE MALADIE RENALE METTANT EN OEUVRE DES GLYCOSAMINOGLYCANES
Publication
Application
Priority
- US 2005035790 W 20051003
- US 61547204 P 20041001
- US 62233204 P 20041026
Abstract (en)
[origin: WO2006039709A1] The present invention relates to methods for the treatment of kidney disease by the administration of at least one glycosaminoglycan to a patient in need of such treatment. In particular, the kidney disease is focal segmental glomerulosclerosis (FSGS) and the glycosaminoglycan is sulodexide.
IPC 8 full level
A61K 31/70 (2006.01); A61K 31/726 (2006.01); A61P 13/12 (2006.01)
CPC (source: EP)
A61K 31/70 (2013.01); A61K 31/726 (2013.01); A61P 3/02 (2017.12); A61P 3/06 (2017.12); A61P 5/40 (2017.12); A61P 7/12 (2017.12); A61P 9/12 (2017.12); A61P 13/12 (2017.12); A61P 31/04 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
WO 2006039709 A1 20060413; AU 2005292202 A1 20060413; CA 2583079 A1 20060413; EP 1804810 A1 20070711; EP 1804810 A4 20080227; IL 182353 A0 20080413; JP 2008515807 A 20080515
DOCDB simple family (application)
US 2005035790 W 20051003; AU 2005292202 A 20051003; CA 2583079 A 20051003; EP 05807269 A 20051003; IL 18235307 A 20070401; JP 2007534903 A 20051003